China Biologic Products, Inc. (NASDAQ: CBPO) is the largest non-state-owned plasma-based biopharmaceutical company approved by the Chinese government. Through our indirect majority-owned subsidiaries, Shandong Taibang Biological Products and Guiyang Dalin